amgen
Welcome to the 'amgen' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'amgen'.
Are you an expert about 'amgen'? Do you want to be the Technorati authority on 'amgen'? You can write a description that will appear right here:
Join Blogcritics!
Original Technorati articles tagged “amgen”
-
in BusinessColorado Startup VetDC Targets Biotech Breakthroughs for Pets

Colorado State University Spinoff Signs Licensing Deal for Cancer Drugby johnjegan / on Mar 16, 2011
Latest blogosphere posts tagged “amgen”
-
Pharmalot… Pharmalittle… The Weekend Nears
Pharmalot —
Authority: 581
And so, yet another working week will soon draw to a close. As you know, this gives us permission to daydream about weekend plans. We have a very modest agenda, though. A little exercise, a few naps and catching up on some reading. And you? Anything interesting planned? Perhaps, this is an opportunity to spend a few ...4 days ago -
Affymax Prepares to Mount First Challenge to Amgen Anemia Drug Monopoly
Xconomy —
Authority: 643
Luke Timmerman Affymax shocked the world when an FDA advisory committee recommended last month that its anemia drug was good enough to earn a spot on the U.S. market. Now the Palo Alto, CA-based company (NASDAQ: AFFY ) is making all sorts of moves behind the scenes that will determine how big a bite it will ...1 week ago -
Stocks at New Highs: Gilead Sciences and Amgen
The Forex Trading System —
Authority: 149
The major market indexes have spent most of the session comfortably higher, thanks to celebrated earnings from Goldman Sachs (GS)…( Read More ) SchaeffersResearch.com Trading Floor Blog Stocks at New Highs: Gilead Sciences and Amgen is a post from: The Forex Trading System Blog1 week ago -
Takeda Plans To Cut 2,800 Jobs In US & Europe
Pharmalot —
Authority: 581
Three months after completing its $13 billion acquisition of Nycomed, Takeda Pharmaceuticals now plans to cut roughly 10 percent of its workforce, or 2,800 jobs - about 2,100 from Europe and 700 from the US - by 2016 in order to save approximately $2.6 billion. The reorganization will include closing an unspecified ...1 week ago -
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge
Xconomy —
Authority: 643
Luke Timmerman Bayer and Onyx Pharmaceuticals looked like they hit gold last fall, when a study of 760 patients showed that one of their new cancer drugs was able to help patients with colorectal cancer live longer. Today, researchers got the first glimpse at the detailed results, and while it’s encouraging news ...2 weeks ago -
Seeking Artwork Submissions for 2012 Amgen Breakaway from Cancer Most Courageous Rider Jersey
Inland Empire News —
Authority: 112
AEG, presenter of the Amgen Tour of California, is seeking original artwork submissions for the design of the 2012 Amgen Breakaway from Cancer® Most Courageous Rider Jersey. This jersey is awarded daily to the cyclist who best exemplifies the character of those engaged in the fight against cancer – courage, ...2 weeks ago -
Pharmalot… Pharmalittle… Good Morning
Pharmalot —
Authority: 581
Good morning, everyone. And a soggy one, it is. Buckets of rain have been falling on the Pharmalot corporate campus. Nonetheless, our spirits are sunny. You know our mantra - every brand new day should be unwrapped like a precious gift. And we mean it. So we are ignoring the cloudy skies with a delicious cup of ...2 weeks ago -
Bikes of the Pros: 2012 Edition
Bike World News —
Authority: 431
Being the bike geek that I am, the annual "Bikes of the Pros" article is always one of my favorites to do. So here they are - all of the bikes ridden in the Pro Tour peloton for 2012 [[ This is a content summary only. Visit my website for full links, other content, and more! ]]2 weeks ago -
Amgen, CVS, Celgene, Home Depot Achieve New 52-Week Highs
Wall St. Cheat Sheet —
Authority: 608
As the U.S. financial markets are gradually approaching annual highs, some companies are already winning at their highest prices in 52 weeks: Amgen Inc. ( NASDAQ:AMGN ): Dako and Amgen will design a cancer drug candidate diagnostic test under a new development and collaboration agreement. “I am proud to announce ...3 weeks ago -
New DNA reader to move promise
Los Angeles Dentist Blog —
Authority: 119
By Sharon Begley NEW YORK | Tue Jan 10, 2012 7:53am EST NEW YORK (Reuters) – A new DNA reader could move genetics to medical clinics. After years of predictions that a “$1,000 genome” – a read-out of a person’s finish genetic information for about a cost of a dental crown ...3 weeks ago -
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Xconomy —
Authority: 643
Luke Timmerman Biotech pilgrims are gathering today for the biggest industry frenzy of the year, the JP Morgan Healthcare Conference . This confab in San Francisco’s Union Square is the singular place each year where essentially all industry mover/shakers—and many wannabes—gather for a marathon week of ...3 weeks ago -
FDA To Review Potential New Use Of XGEVA® (Denosumab)
Los Angeles Dentist Blog —
Authority: 119
Thousand Oaks, CA /PRNewswire/ – Amgen (NASDAQ: AMGN ) now announced a U.S. Food and Drug Administration (FDA) has invited a Company to attend in a assembly of a Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to plead a supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to provide ...3 weeks ago -
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug
Xconomy —
Authority: 643
Luke Timmerman Alnylam Pharmaceuticals has been saying for a while that it needs hard data from clinical trials to prove its skeptics wrong, and today it’s coming out with an early hint of effectiveness with its RNA interference-based treatment for lowering cholesterol. Cambridge, MA-based Alnylam (NASDAQ: ...3 weeks ago



Follow Technorati